![Brian Stuglik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Stuglik
Directeur/Membre du Conseil chez
VERASTEM, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Mr. Brian M.
Stuglik is an Independent Director at Puma Biotechnology, Inc., an Independent Director at Oncopeptides AB, a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology, Inc. and a Member at International Association for the Study of Lung Cancer.
He is on the Board of Directors at Puma Biotechnology, Inc., Oncopeptides AB and Verastem, Inc. Mr. Stuglik was previously employed as a Member by Proventus Health Solutions LLC and a Chief Marketing Officer-Oncology Division & VP by Eli Lilly & Co. He received his undergraduate degree from Purdue University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC. 0,22 % | 12/06/2026 | 113 858 ( 0,22 % ) | 816 362 $ | 31/05/2026 |
VERASTEM, INC. 0,22 % | 21/05/2026 | 137 147 ( 0,22 % ) | 593 847 $ | 31/05/2026 |
ONCOPEPTIDES AB 0,04 % | 31/12/2024 | 154 828 ( 0,04 % ) | 30 351 $ | 31/05/2026 |
Postes actifs de Brian Stuglik
| Sociétés | Poste | Début |
|---|---|---|
| VERASTEM, INC. | Directeur/Membre du Conseil | 02/09/2017 |
| ONCOPEPTIDES AB | Directeur/Membre du Conseil | 17/05/2018 |
| PUMA BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 05/07/2020 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
International Association for the Study of Lung Cancer
 International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a global organization dedicated to the research and study of lung cancer. The company is based in Aurora, CO. With a focus on advancing the understanding and treatment of lung cancer, the IASLC brings together researchers, healthcare professionals, and advocates from around the world. Through collaboration and education, the organization aims to improve patient outcomes and reduce the global burden of lung cancer. | Corporate Officer/Principal | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | - |
Anciens postes connus de Brian Stuglik
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/12/2015 |
Proventus Health Solutions LLC
 Proventus Health Solutions LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical companies in oncology drug development process | Fondateur | - |
Formation de Brian Stuglik
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
International Association for the Study of Lung Cancer
International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a global organization dedicated to the research and study of lung cancer. The company is based in Aurora, CO. With a focus on advancing the understanding and treatment of lung cancer, the IASLC brings together researchers, healthcare professionals, and advocates from around the world. Through collaboration and education, the organization aims to improve patient outcomes and reduce the global burden of lung cancer. | Commercial Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Proventus Health Solutions LLC
Proventus Health Solutions LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical companies in oncology drug development process | Commercial Services |
